Related references
Note: Only part of the references are listed.A multicentre validation study of the diagnostic value of plasma neurofilament light
Nicholas J. Ashton et al.
Nature Communications (2021)
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia
Shorena Janelidze et al.
NATURE MEDICINE (2020)
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration
Elisabeth H. Thijssen et al.
NATURE MEDICINE (2020)
Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET
Renaud La Joie et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders
Antoine Leuzy et al.
JAMA NEUROLOGY (2020)
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling data from four cohorts
Thomas K. Karikari et al.
LANCET NEUROLOGY (2020)
Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline
Juan Lantero Rodriguez et al.
ACTA NEUROPATHOLOGICA (2020)
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
Sebastian Palmqvist et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration
Alberto Benussi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
Nelly Siller et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
Nelly Siller et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
Niklas Mattsson et al.
JAMA NEUROLOGY (2019)
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
Suzanne E. Schindler et al.
NEUROLOGY (2019)
Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status
Sebastian Palmqvist et al.
JAMA NEUROLOGY (2019)
Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment
Patrick Oeckl et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis
Federico Verde et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Biomarkers for tau pathology
Michael Scholl et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2019)
Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration
Nicholas J. Ashton et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals
Andrea L. Benedet et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2019)
Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
Michelle M. Mielke et al.
ALZHEIMERS & DEMENTIA (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Update on biomarkers for amyloid pathology in Alzheimer's disease
Nicholas J. Ashton et al.
BIOMARKERS IN MEDICINE (2018)
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Akinori Nakamura et al.
NATURE (2018)
Neurofilament relates to white matter microstructure in older adults
Elizabeth E. Moore et al.
NEUROBIOLOGY OF AGING (2018)
Comparing F-18-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease
Niklas Mattsson et al.
NEUROLOGY (2018)
Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes
Inge M. W. Verberk et al.
ANNALS OF NEUROLOGY (2018)
Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders
Rik Ossenkoppele et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Serum neurofilament light is sensitive to active cerebral small vessel disease
Thomas Gattringer et al.
NEUROLOGY (2017)
Blood-based NfL A biomarker for differential diagnosis of parkinsonian disorder
Oskar Hansson et al.
NEUROLOGY (2017)
Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports
Pashtun Shahim et al.
NEUROLOGY (2017)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
Jonathan D. Rohrer et al.
NEUROLOGY (2016)
Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression
Henrik Zetterberg et al.
JAMA NEUROLOGY (2016)
VoxelStats: A MATLAB Package for Multi-Modal Voxel-Wise Brain Image Analysis
Sulantha Mathotaarachchi et al.
FRONTIERS IN NEUROINFORMATICS (2016)
Plasma neurofilament light chain predicts progression in progressive supranuclear palsy
Julio C. Rojas et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
Magnus Gisslen et al.
EBIOMEDICINE (2016)
Plasma β-amyloid in Alzheimer's disease and vascular disease
Shorena Janelidze et al.
SCIENTIFIC REPORTS (2016)
Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease
Martina Sattlecker et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
The HiveDB image data management and analysis framework
J-Sebastian Muehlboeck et al.
FRONTIERS IN NEUROINFORMATICS (2014)
Plasma tau levels in Alzheimer's disease
Henrik Zetterberg et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
pROC: an open-source package for R and S plus to analyze and compare ROC curves
Xavier Robin et al.
BMC BIOINFORMATICS (2011)
AddNeuroMed-The European Collaboration for the Discovery of Novel Biomarkers for Alzheimer's Disease
Simon Lovestone et al.
BIOMARKERS IN BRAIN DISEASE (2009)
MRI Measures of Alzheimer's Disease and the AddNeuroMed Study
Andrew Simmons et al.
BIOMARKERS IN BRAIN DISEASE (2009)
A fully automatic and robust brain MRI tissue classification method
CA Cocosco et al.
MEDICAL IMAGE ANALYSIS (2003)
Share Paper
